Membrane Tumor Necrosis Factor (TNF) Induced Cooperative Signaling of TNFR60 and TNFR80 Favors Induction of Cell Death Rather Than Virus Production in HIV-infected T Cells

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1997 Jan 6

PMID 8996244

Citations 21

Authors

J K Lazdins

M Grell

M R Walker

P Scheurich

K Pfizenmaier

Affiliations

Soon will be listed here.

Abstract

Tumor necrosis factor (TNF) and lymphotoxin (LT) are highly pleiotropic cytokines that play a central role in regulating HIV-1 replication. These cytokines express their activities through two membrane receptors, TNFR60 (p55-60) and TNFR80 (p75-80). In the present study we have demonstrated by means of antagonistic and agonistic receptor-specific antibodies that in latently infected lymphocytic (ACH-2) cells the TNFR60 plays a dominant role in signaling HIV production, although selective activation of TNFR80 by receptor-specific antibodies can also induce HIV production. Unexpectedly, when both TNFRs were activated simultaneously by agonistic antibodies or coculture with cells expressing a noncleavable membrane form of TNF, HIV production was downregulated and induction of cell death was enhanced in ACH-2 cells. More relevant, in vitro HIV-infected peripheral blood lymphocytes cocultured with cells expressing membrane TNF underwent rapid induction of apoptosis with a subsequent reduced HIV production of these lymphocytes cultures. This was not observed with HIV-infected lymphocytes treated with soluble TNF. These data provide evidence for the differential trigger potential of membrane versus soluble TNF and show that TNFR80 is an important modulator of TNF responsiveness of HIV-infected T cells via cooperative signaling with TNFR60.

Citing Articles

Discovering the Mechanisms of Oleodaphnone as a Potential HIV Latency-Reversing Agent by Transcriptome Profiling.

Li S, Wang X, Yang Y, Wu X, Zhang L Int J Mol Sci. 2023; 24(8).

PMID: 37108519 PMC: 10138910. DOI: 10.3390/ijms24087357.

Comprehensive analysis of DNA methylation for periodontitis.

Zhao Z, Wang H, Li X, Hou J, Yang Y, Li H Int J Implant Dent. 2022; 8(1):22.

PMID: 35491409 PMC: 9058047. DOI: 10.1186/s40729-022-00420-8.

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA.

Moyo N, Vogel A, Buus S, Erbar S, Wee E, Sahin U Mol Ther Methods Clin Dev. 2018; 12:32-46.

PMID: 30547051 PMC: 6258890. DOI: 10.1016/j.omtm.2018.10.010.

Long-term follow up of human T-cell responses to conserved HIV-1 regions elicited by DNA/simian adenovirus/MVA vaccine regimens.

Moyo N, Borthwick N, Wee E, Capucci S, Crook A, Dorrell L PLoS One. 2017; 12(7):e0181382.

PMID: 28719652 PMC: 5515449. DOI: 10.1371/journal.pone.0181382.

Mycobacterial and HIV infections up-regulated human zinc finger protein 134, a novel positive regulator of HIV-1 LTR activity and viral propagation.

Benjamin R, Banerjee A, Balakrishnan K, Sivangala R, Gaddam S, Banerjee S PLoS One. 2014; 9(8):e104908.

PMID: 25144775 PMC: 4140746. DOI: 10.1371/journal.pone.0104908.

References

Mellors J, Griffith B, Ortiz M, Landry M, Ryan J . Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J Infect Dis. 1991; 163(1):78-82. DOI: 10.1093/infdis/163.1.78. View

Schmid E, Binder K, Grell M, Scheurich P, Pfizenmaier K . Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood. 1995; 86(5):1836-41. View

Tartaglia L, WEBER R, Figari I, Reynolds C, Palladino Jr M, Goeddel D . The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci U S A. 1991; 88(20):9292-6. PMC: 52700. DOI: 10.1073/pnas.88.20.9292. View

Birkland T, Sypek J, Wyler D . Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J Leukoc Biol. 1992; 51(3):296-9. DOI: 10.1002/jlb.51.3.296. View

Matsuyama T, Kobayashi N, Yamamoto N . Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?. AIDS. 1991; 5(12):1405-17. DOI: 10.1097/00002030-199112000-00001. View

Liu A, Miskovsky E, Stanhope P, Siliciano R . Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism. J Immunol. 1992; 148(12):3789-98. View

Tartaglia L, Goeddel D . Two TNF receptors. Immunol Today. 1992; 13(5):151-3. DOI: 10.1016/0167-5699(92)90116-O. View

Wiegmann K, Schutze S, Kampen E, Himmler A, Machleidt T, Kronke M . Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J Biol Chem. 1992; 267(25):17997-8001. View

Barre-Sinoussi F, Chermann J, Rey F, Nugeyre M, Chamaret S, Gruest J . Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983; 220(4599):868-71. DOI: 10.1126/science.6189183. View

10.

Willey R, Smith D, Lasky L, THEODORE T, Earl P, Moss B . In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol. 1988; 62(1):139-47. PMC: 250512. DOI: 10.1128/JVI.62.1.139-147.1988. View

11.

Lahdevirta J, Maury C, Teppo A, Repo H . Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med. 1988; 85(3):289-91. DOI: 10.1016/0002-9343(88)90576-1. View

12.

Matsuyama T, Hamamoto Y, Kobayashi S, Kurimoto M, Minowada J, Kobayashi N . Enhancement of human immunodeficiency virus production by natural lymphotoxin. Med Microbiol Immunol. 1988; 177(4):181-7. DOI: 10.1007/BF00211217. View

13.

Schols D, Pauwels R, Vanlangendonck F, Balzarini J, De Clercq E . A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells. J Immunol Methods. 1988; 114(1-2):27-32. DOI: 10.1016/0022-1759(88)90149-4. View

14.

Clouse K, Powell D, Washington I, Poli G, Strebel K, Farrar W . Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol. 1989; 142(2):431-8. View

15.

Osborn L, Kunkel S, Nabel G . Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989; 86(7):2336-40. PMC: 286907. DOI: 10.1073/pnas.86.7.2336. View

16.

Folks T, Clouse K, Justement J, Rabson A, Duh E, Kehrl J . Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A. 1989; 86(7):2365-8. PMC: 286913. DOI: 10.1073/pnas.86.7.2365. View

17.

Griffin G, Leung K, Folks T, Kunkel S, Nabel G . Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature. 1989; 339(6219):70-3. DOI: 10.1038/339070a0. View

18.

Michihiko S, Yamamoto N, Shinozaki F, Shimada K, Soma G, Kobayashi N . Augmentation of in-vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumour necrosis factor. Lancet. 1989; 1(8648):1206-7. DOI: 10.1016/s0140-6736(89)92788-8. View

19.

Duh E, Maury W, Folks T, Fauci A, Rabson A . Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A. 1989; 86(15):5974-8. PMC: 297754. DOI: 10.1073/pnas.86.15.5974. View

20.

Merrill J, Koyanagi Y, Chen I . Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol. 1989; 63(10):4404-8. PMC: 251058. DOI: 10.1128/JVI.63.10.4404-4408.1989. View